Source Data Verification

The Swedish Breast Cancer Group conducted a nationwide clinical trial, examining radiotherapy significance of Ductal carcinoma in situ of the breast. The trial collected data from 1047 randomized patients.

Prior to database lock in the Northern region, A+ Science was asked to provide source data verification . Swift and accurate completion resulted in A+ Science supporting other regions as well. The study was later published.

A+ Science is now entrusted with data entry and source data verification for the Swedish Breast Cancer Groups next trial: a cohort study of the significance of abstained axils surgery, recruiting 1600 patients with screened tumors below 10 mm. The Northern region included 230 subjects.

Available personnel, working independently at a fixed fee and delivery within timelines made us choose A+ for our next trial as well.

Customer from the Swedish Breast Cancer Group

Return to case study list